IPS interviews head of Cuban research team working to develop dengue vaccine

Nov 17 2011

Inter Press Service interviews Maria Guadalupe Guzman, head of the Pedro Kouri Institute (IPK) Department of Virology and director of the PAHO/WHO Collaborating Centre for the Study of Dengue and its Vector, who is leading of a team of Cuban researchers working to develop a vaccine against dengue. In the interview, Guzman discusses Cuba's contributions to the field of dengue research, the influence of climate change on the transmission of dengue, and differences in the four strains of the virus (Grogg, 11/15).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Research News | Disease/Infection News

Tags: , , , , ,

Comments (0)

Suggested Reading

T cells can completely prevent viral infections in humans
New research identifies metabolic targets to combat antibiotic-resistant bacterial infections
Being fit matters more than weight for long-term health, research shows
COVID-19 vaccine gaps linked to higher hospitalization and death rates in the UK
AstraZeneca's Pioneering Research in Heart Failure and ATTR-CM
Global research uncovers varying diabetes mortality risks by ethnicity
UQ and Vaxxas win global prize to accelerate patch-based mRNA vaccine for COVID-19
UK researchers outline strategy for cancer vaccine advancements

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Study uncovers why lupus patients have weaker response to COVID-19 vaccines